2019

➣ Nucleotron MIT partners with GE in the Phase II clinical Trial for Cardiac PET myocardial perfusion imaging using the novel tracer, F18-Flurpiridaz.

➣ Nucleotron MIT partners with a number of global Radio-pharmaceutical and research companies in clinical validation  of novel amyloid and Tau tracers for Alzheimer diagnosis.

➣ Nucleotron MIT partners with Ionetix Corporation to introduce the first NH3 Ammonia production site in South Florida with the installation of the ION 12SC.

➣ Nucleotron MIT formally partners with Ionetix Corporation to introduce the ION 12SC Cyclotron in Latin America.

Scroll to Top